Director Global Market Access Oncology Early Assets/Business Development

Job description

Working with Us Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible. Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us. Summary: The Director, Global Market Access Oncology Early Assets & Business Development, will provide value, access, and pricing considerations in a systematic way into the product development governance process to help maximize the value of the BMS oncology portfolio and life cycle management. Reporting to the Executive Director, Oncology Market Access Strategy Integration, Early Assets & Business Development, the Director will lead the development of early market access strategies within assigned oncology asset(s) or sub-portfolio, and relevant business development activities. Key activities include providing strategic access input into the governance process to help determine where to play and how to win, particularly in the context of evolving drug pricing reforms and a complex market access environment with high levels of uncertainty. Responsibilities: Lead early market access strategy for assigned pipeline oncology compounds/indications, partnering closely with clinical development, early commercialization, and cross functional stakeholders, and represent MAx on relevant Clinical Development Team / Global Program Team where relevant. Inform the future access strategy for new compounds by helping assess clinical development strategies; contribute to the evidence generation plan and mitigation activities to address key market access and pricing opportunities and challenges. Provide oncology MAx input on Business Development requests from early commercialization and M&A/BD&L to assess access and pricing considerations and inform valuation, and represent MAx on the Valuation Core Team as needed. Lead above asset projects and workstreams to continue to evolve the oncology MAx expertise and capabilities for Early Assets and BD. Monitor the evolving external environment and synthesize input to inform Market Access strategies, ensuring access and value considerations (e.g., relevant endpoints, comparator, dosing, study population, subpopulation of interest) are reflected in protocol design, in collaboration with the cross-functional team (PASL, Pricing, HEOR, Medical & Local Markets). Partner with cross-functional Market Access teams and extended teams (Commercial, Clinical Development, Business Development, Forecasting, etc.) as well as relevant individual market stakeholders to help optimally position BMS products for success in an increasingly challenging and evolving access landscape. Qualifications: Undergraduate degree required; MBA / MPH / PharmD or relevant post-graduate degree preferred. Minimum of 8+ years of Market Access / Commercial experience with a strong track record in market access strategy, pricing, and/or HEOR in global and/or US markets. Solid understanding of the current and emerging Market Access environment in oncology/hematology. Good working knowledge of the drug development & commercialization process, HTA assessment methodologies, global reimbursement environment, and regulatory requirements, including an understanding of payers and their perspective in key markets. Scientific background, preferably within oncology/hematology, supporting the assessment of trial design impact on payer strategies and the ability to partner with clinical development or medical affairs to help identify relevant clinical endpoints and outcomes research needs in early phases of clinical trial development. Demonstrated ability to contribute to Market Access strategic scenarios and to work effectively within cross-functional teams, with or without formal authority. Proven ability to articulate and support the translation of scientific/clinical value into economic value. Demonstration of all BMS Values. #LI-Hybrid If you come across a role that intrigues you but doesn’t perfectly line up with your resume, we encourage you to apply anyway. You could be one step away from work that will transform your life and career. Compensation Overview: Princeton - NJ - US: $196,390 - $237,982 The starting compensation range(s) for this role are listed above for a full-time employee (FTE) basis. Additional incentive cash and stock opportunities (based on eligibility) may be available. The starting pay rate takes into account characteristics of the job, such as required skills, where the job is performed, the employee’s work schedule, job-related knowledge, and experience. Final, individual compensation will be decided based on demonstrated experience. Eligibility for specific benefits listed on our careers site may vary based on the job and location. For more on benefits, please visit https://careers.bms.com/life-at-bms/. Benefit offerings are subject to the terms and conditions of the applicable plans in effect at the time and may require enrollment. Our benefits include: Health Coverage: Medical, pharmacy, dental, and vision care. Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP). Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support. ​Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day. All global employees full and part-time who are actively employed at and paid directly by BMS at the end of the calendar year are eligible to take advantage of the Global Shutdown. *Eligibility Disclosure: The summer hours program is for United States (U.S.) office-based employees due to the unique nature of their work. Summer hours are generally not available for field sales and manufacturing operations and may also be limited for the capability centers. Employees in remote-by-design or lab-based roles may be eligible for summer hours, depending on the nature of their work, and should discuss eligibility with their manager. Employees covered under a collective bargaining agreement should consult that document to determine if they are eligible. Contractors, leased workers and other service providers are not eligible to participate in the program. Uniquely Interesting Work, Life-changing Careers With a single vision as inspiring as “Transforming patients’ lives through science™ ”, every BMS employee plays an integral role in work that goes far beyond ordinary. Each of us is empowered to app